Seòmar agus comataidhean

I refer the member to the Scottish Government’s second Tackling Child Poverty Delivery Plan which committed to offering up to 500 apprenticeship opportunities across NHS Scotland in 2022/23.

NHS Boards deliver a wide range of employability programmes, following the ‘No One Left Behind’ overarching approach which is place-based, needs-led and person-centred. Programmes delivered in 2022-23 have focused on a wide range of groups, including: young people at risk of long-term unemployment, care leavers, veterans and service leavers, and lone parents over the age of 25.

The Scottish Government’s Chief Scientist Office (CSO) supports funding schemes for applied health research across the range of health challenges including prevention and treatment of infectious diseases. Applications are assessed through independent expert review with funding decisions based on the recommendations of independent expert research committees. Currently funded projects include an investigation of a novel class of antibiotic and on targeting antibiotic use.

In addition, CSO contributes financially to a range of National Institute for Health & Care Research funding schemes so these are open to applications from researchers in Scotland. These schemes can also consider applications for research relating to infectious diseases with funding recommendations made following independent expert review.

CSO also invests through NHS Research Scotland in a range of clinical research infrastructure to support Health Boards to host and participate in clinical studies and trials, including an Infectious Diseases Clinical Research Network to support the delivery of studies in this area.

The Scottish Government has also agreed, in principle, to join a new payment and evaluation model for new antimicrobial products, led by National Institute for Health & Care Excellence and NHS England. Frameworks are set to be finalised and in place by end of March 2023, at which point, all four nations will collectively decide on the new products that will be awarded contracts. If this new model is successful, we hope it will help to address supply chain issues by incentivising industry research and development into new antimicrobials.

As committed to in the National Workforce Strategy for Health and Social Care, we have been undertaking a data collection exercise to inform future decisions about workforce investment. This work is being led by the Scottish Cancer Network, which is engaging with local boards and professional representatives.

A final report, including recommendations, will be provided to the National Oncology Taskforce in the first quarter of 2023. The Taskforce is made up of NHS Board Chief Executives and Medical Directors, and will seek national solutions to ensure the longer term resilience of oncology services in Scotland.

The following table shows the amount spent by the Tobacco Team in each year since 2017-18. Due to way in which spend is recorded it is not possible to disaggregate Tobacco Control spend from overall Tobacco spend. Also please note that 2022-23 spend is not included as this financial year has not yet concluded.

The Scottish Government has had no discussions with the UK Government regarding any poor customer service processes and response times at the Medicines and Healthcare products Regulatory Agency. No businesses have raised any concerns with the Scottish Government on this matter.

This work was agreed in February 2020 however was subsequently paused due to capacity issues related to the COVID-19 pandemic. It will be further considered by the National Advisory Committee for Neurological Conditions alongside our emerging priorities for implementation of the commitments within the Neurological Care and Support: Framework for Action 2020-2025 .

Commitment 13 in the Neurological Care and Support: Framework for Action 2020-2025 relates to the support of research into neurological conditions

Action to support Commitment 13 of the Neurological Care and Support: Framework for Action 2020-25 is detailed in the response to Parliamentary Question S6W-13711 on 23 January 2023. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

In 2019, we published a Neurological Care and Support – a National Framework for Action 2020-25 , with a vision to ensure everyone with a neurological condition can access the care and support they need to live well, on their own terms.

The aims include improving the provision of co-ordinated health and social care and support, developing sustainable workforce models and ensuring high standards of person-centred care.

Despite the disruption to health and social care services during the pandemic, we have sustained our efforts to deliver the 17 commitments of the Framework. Since October 2020 we have we have awarded £2.1 million to fund innovative projects by NHS Boards, Health and Social Care Partnerships and third sector organisations working to achieve better outcomes for people living with neurological conditions.

I further refer the member to the Neurological Care And Support: A Framework For Action 2020-2025 – Midpoint Progress Report , which was published on 13 July 2022. This report provides an update on the progress under each of the five aims in the Neurological Care And Support: A Framework For Action 2020-2025.

I refer the member to the answer to question S6W-13716 on 23 January 2023. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

On 13 December 2022 we published a report of the estimated prevalence of 28 specific neurological conditions: Neurological Conditions: estimating the prevalence in Scotland of selected conditions using GP and Hospital Admissions datasets - gov.scot (www.gov.scot) .

The work was initiated by the Scottish Government and supported by Public Health Scotland (PHS). Estimates were derived from GP recorded diagnoses and hospital admissions data.

The report addresses the commitment in the Neurological Care and Support: Framework for Action 2020-2025 to develop more accurate epidemiological data.

Undertaking this work has enabled us to begin looking at how neurological diagnoses are recorded in health and care records, and how we gather and report prevalence.